A Bayesian pharmacokinetics integrated phase I-II design to optimize dose-schedule regimes
{{output}}
The schedule of administering a drug has profound impact on the toxicity and efficacy profiles of the drug through changing its pharmacokinetics (PK). PK is an innate and indispensable component of the dose-schedule optimization. Motivated by this, we propose ... ...
